marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q2
added 08-15-2024
Titan Pharmaceuticals Cash Flow 2011-2024 | TTNP
Annual Cash Flow Titan Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-7.09 M | -8.18 M | -7.9 M | -17.2 M | -15.4 M | -8.43 M | -12.7 M | 6.29 M | -7.47 M | - | - | 1.83 M | -14.5 M |
Depreciation & Amortization |
112 K | 196 K | 221 K | 292 K | 244 K | 380 K | 417 K | 377 K | 358 K | 353 K | 107 K | 17 K | 32 K |
Accounts Payables |
348 K | 695 K | 795 K | 1.25 M | 1.4 M | 1.53 M | 821 K | 3.02 M | 4.16 M | 4.41 M | 5.12 M | 3.77 M | 4.79 M |
Accounts Receivables |
46 K | 36 K | 112 K | 884 K | 993 K | 1.74 M | 65 K | 3.59 M | 4.21 M | 3.97 M | 4.82 M | 4.65 M | 3.72 M |
Total Inventories |
- | 106 K | 293 K | 328 K | 998 K | 1.26 M | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Titan Pharmaceuticals
| 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | -613 K | - | - | - | -1.9 M | - | -6.6 M | -4.73 M | -2.96 M | - | -6.82 M | -4.56 M | -2.62 M | - | -12.6 M | -9.2 M | -5.21 M | - | -11.8 M | -8.46 M | -4.31 M | - | -5.12 M | -2.86 M | -999 K | - | -9.18 M | -5.63 M | -3.11 M | - | 8.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | -1.7 M | - | -7.57 M | -5.19 M | -2.53 M | - | -12.3 M | -8.97 M | -2.11 M |
Depreciation & Amortization |
- | 2 K | - | - | - | 43 K | - | 151 K | 103 K | 52 K | - | 168 K | 112 K | 55 K | - | 227 K | 128 K | 62 K | - | 186 K | 123 K | 60 K | - | 337 K | 224 K | 112 K | - | 308 K | 203 K | 101 K | - | 279 K | 186 K | 93 K | - | 265 K | 177 K | 89 K | - | 265 K | 176 K | 88 K | - | 19 K | 12 K | 5 K | - | 13 K | 9 K | 5 K | - | 26 K | 19 K | 10 K |
Accounts Payables |
356 K | 371 K | 348 K | 407 K | 597 K | 567 K | 695 K | 812 K | 443 K | 468 K | 795 K | 386 K | 439 K | 768 K | 1.25 M | 1.25 M | 1.25 M | 1.25 M | 815 K | 1.4 M | 1.4 M | 1.4 M | 1.53 M | 1.53 M | 1.53 M | 1.53 M | 821 K | 821 K | 821 K | 821 K | 3.02 M | 3.02 M | 3.02 M | 3.02 M | 4.16 M | 4.16 M | 4.16 M | 4.16 M | 4.41 M | 4.41 M | 4.41 M | 4.41 M | 5.12 M | 5.12 M | 5.12 M | 5.12 M | 3.77 M | 3.77 M | 3.77 M | 3.77 M | 4.79 M | 4.79 M | 4.79 M | 4.79 M |
Accounts Receivables |
38 K | 134 K | 46 K | 26 K | 9 K | 8 K | 36 K | 49 K | 101 K | 218 K | 112 K | 265 K | 103 K | 398 K | 884 K | 884 K | 884 K | 884 K | 438 K | 993 K | 993 K | 993 K | 1.74 M | 1.74 M | 1.74 M | 1.74 M | 65 K | 65 K | 65 K | 65 K | 3.59 M | 3.59 M | 3.59 M | 3.59 M | 4.21 M | 4.21 M | 4.21 M | 4.21 M | 3.97 M | 3.97 M | 3.97 M | 3.97 M | 4.82 M | 4.82 M | 4.82 M | 4.82 M | 4.65 M | 4.65 M | 4.65 M | 4.65 M | 3.72 M | 3.72 M | 3.72 M | 3.72 M |
Total Inventories |
- | - | - | - | - | 106 K | 106 K | 460 K | 469 K | 293 K | 293 K | 129 K | 129 K | 218 K | 328 K | 328 K | 328 K | 328 K | 563 K | 998 K | 998 K | 998 K | 1.26 M | 1.26 M | 1.26 M | 1.26 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency